151 related articles for article (PubMed ID: 25187396)
21. Focal adhesion kinase as a marker of malignant phenotype in breast and cervical carcinomas.
Oktay MH; Oktay K; Hamele-Bena D; Buyuk A; Koss LG
Hum Pathol; 2003 Mar; 34(3):240-5. PubMed ID: 12673558
[TBL] [Abstract][Full Text] [Related]
22. Effect of epidermal growth factor receptor tyrosine kinase inhibition on epithelial proliferation in normal and premalignant breast.
Chan KC; Knox WF; Gee JM; Morris J; Nicholson RI; Potten CS; Bundred NJ
Cancer Res; 2002 Jan; 62(1):122-8. PubMed ID: 11782368
[TBL] [Abstract][Full Text] [Related]
23. Cyclooxygenase-2 expression in human breast cancers and adjacent ductal carcinoma in situ.
Half E; Tang XM; Gwyn K; Sahin A; Wathen K; Sinicrope FA
Cancer Res; 2002 Mar; 62(6):1676-81. PubMed ID: 11912139
[TBL] [Abstract][Full Text] [Related]
24. The target for statins, HMG-CoA reductase, is expressed in ductal carcinoma-in situ and may predict patient response to radiotherapy.
Butt S; Butt T; Jirström K; Hartman L; Amini RM; Zhou W; Wärnberg F; Borgquist S
Ann Surg Oncol; 2014 Sep; 21(9):2911-9. PubMed ID: 24777857
[TBL] [Abstract][Full Text] [Related]
25. AURKA governs self-renewal capacity in glioma-initiating cells via stabilization/activation of β-catenin/Wnt signaling.
Xia Z; Wei P; Zhang H; Ding Z; Yang L; Huang Z; Zhang N
Mol Cancer Res; 2013 Sep; 11(9):1101-11. PubMed ID: 23761169
[TBL] [Abstract][Full Text] [Related]
26. AurkA controls self-renewal of breast cancer-initiating cells promoting wnt3a stabilization through suppression of miR-128.
Eterno V; Zambelli A; Villani L; Tuscano A; Manera S; Spitaleri A; Pavesi L; Amato A
Sci Rep; 2016 Jun; 6():28436. PubMed ID: 27341528
[TBL] [Abstract][Full Text] [Related]
27. Intrinsic focal adhesion kinase activity controls orthotopic breast carcinoma metastasis via the regulation of urokinase plasminogen activator expression in a syngeneic tumor model.
Mitra SK; Lim ST; Chi A; Schlaepfer DD
Oncogene; 2006 Jul; 25(32):4429-40. PubMed ID: 16547501
[TBL] [Abstract][Full Text] [Related]
28. Lapatinib inhibits stem/progenitor proliferation in preclinical in vitro models of ductal carcinoma in situ (DCIS).
Farnie G; Johnson RL; Williams KE; Clarke RB; Bundred NJ
Cell Cycle; 2014; 13(3):418-25. PubMed ID: 24247151
[TBL] [Abstract][Full Text] [Related]
29. Focal adhesion proteins as markers of malignant transformation and prognostic indicators in breast carcinoma.
Madan R; Smolkin MB; Cocker R; Fayyad R; Oktay MH
Hum Pathol; 2006 Jan; 37(1):9-15. PubMed ID: 16360410
[TBL] [Abstract][Full Text] [Related]
30. [Nuclear beta-catenin localization is not sufficient for canonical Wnt signaling activation in human meianoma cell lines].
Kulikova KV; Posviatenko AV; Gnuchev NV; Georgiev GP; Kibardin AV; Larin SS
Mol Biol (Mosk); 2011; 45(5):884-91. PubMed ID: 22393786
[TBL] [Abstract][Full Text] [Related]
31. Blockade of Wnt/β-catenin signaling suppresses breast cancer metastasis by inhibiting CSC-like phenotype.
Jang GB; Kim JY; Cho SD; Park KS; Jung JY; Lee HY; Hong IS; Nam JS
Sci Rep; 2015 Jul; 5():12465. PubMed ID: 26202299
[TBL] [Abstract][Full Text] [Related]
32. FAK and WNT signaling: the meeting of two pathways in cancer and development.
Fonar Y; Frank D
Anticancer Agents Med Chem; 2011 Sep; 11(7):600-6. PubMed ID: 21707509
[TBL] [Abstract][Full Text] [Related]
33. β-catenin deacetylation is essential for WNT-induced proliferation of breast cancer cells.
Wang SH; Li N; Wei Y; Li QR; Yu ZP
Mol Med Rep; 2014 Mar; 9(3):973-8. PubMed ID: 24401947
[TBL] [Abstract][Full Text] [Related]
34. A diterpenoid compound, excisanin A, inhibits the invasive behavior of breast cancer cells by modulating the integrin β1/FAK/PI3K/AKT/β-catenin signaling.
Qin J; Tang J; Jiao L; Ji J; Chen WD; Feng GK; Gao YH; Zhu XF; Deng R
Life Sci; 2013 Nov; 93(18-19):655-63. PubMed ID: 24044886
[TBL] [Abstract][Full Text] [Related]
35. Regulation of Wnt signaling activity for growth suppression induced by quercetin in 4T1 murine mammary cancer cells.
Kim H; Seo EM; Sharma AR; Ganbold B; Park J; Sharma G; Kang YH; Song DK; Lee SS; Nam JS
Int J Oncol; 2013 Oct; 43(4):1319-25. PubMed ID: 23900432
[TBL] [Abstract][Full Text] [Related]
36. The direct effect of focal adhesion kinase (FAK), dominant-negative FAK, FAK-CD and FAK siRNA on gene expression and human MCF-7 breast cancer cell tumorigenesis.
Golubovskaya VM; Zheng M; Zhang L; Li JL; Cance WG
BMC Cancer; 2009 Aug; 9():280. PubMed ID: 19671193
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of FAK kinase activity preferentially targets cancer stem cells.
Kolev VN; Tam WF; Wright QG; McDermott SP; Vidal CM; Shapiro IM; Xu Q; Wicha MS; Pachter JA; Weaver DT
Oncotarget; 2017 Aug; 8(31):51733-51747. PubMed ID: 28881682
[TBL] [Abstract][Full Text] [Related]
38. Prostate tumour overexpressed-1 promotes tumourigenicity in human breast cancer via activation of Wnt/β-catenin signalling.
Cui Y; Ma W; Lei F; Li Q; Su Y; Lin X; Lin C; Zhang X; Ye L; Wu S; Li J; Yuan Z; Song L
J Pathol; 2016 Jul; 239(3):297-308. PubMed ID: 27060981
[TBL] [Abstract][Full Text] [Related]
39. PKM2 promotes stemness of breast cancer cell by through Wnt/β-catenin pathway.
Zhao Z; Song Z; Liao Z; Liu Z; Sun H; Lei B; Chen W; Dang C
Tumour Biol; 2016 Mar; 37(3):4223-34. PubMed ID: 26493994
[TBL] [Abstract][Full Text] [Related]
40. Characterization of a stem-like subpopulation in basal-like ductal carcinoma in situ (DCIS) lesions.
Li Q; Eades G; Yao Y; Zhang Y; Zhou Q
J Biol Chem; 2014 Jan; 289(3):1303-12. PubMed ID: 24297178
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
